270 related articles for article (PubMed ID: 16859900)
1. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection.
Uehara S; Monden K; Nomoto K; Seno Y; Kariyama R; Kumon H
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S30-4. PubMed ID: 16859900
[TBL] [Abstract][Full Text] [Related]
2. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
3. Vaginal colonization by orally administered Lactobacillus rhamnosus GG.
Colodner R; Edelstein H; Chazan B; Raz R
Isr Med Assoc J; 2003 Nov; 5(11):767-9. PubMed ID: 14650098
[TBL] [Abstract][Full Text] [Related]
4. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
[TBL] [Abstract][Full Text] [Related]
5. A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis.
Wada K; Uehara S; Ishii A; Sadahira T; Yamamoto M; Mitsuhata R; Takamoto A; Araki M; Kobayashi Y; Watanabe M; Watanabe T; Hotta K; Nasu Y
Acta Med Okayama; 2016 Aug; 70(4):299-302. PubMed ID: 27549677
[TBL] [Abstract][Full Text] [Related]
6. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections.
Reid G; Bruce AW; Taylor M
Clin Ther; 1992; 14(1):11-6. PubMed ID: 1576619
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Lactobacillus vaginal suppositories for the prevention of recurrent cystitis: A phase II clinical trial.
Sadahira T; Wada K; Araki M; Mitsuhata R; Yamamoto M; Maruyama Y; Iwata T; Watanabe M; Watanabe T; Kariyama R; Nasu Y; Ishii A
Int J Urol; 2021 Oct; 28(10):1026-1031. PubMed ID: 34258813
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
Raz R; Colodner R; Rohana Y; Battino S; Rottensterich E; Wasser I; Stamm W
Clin Infect Dis; 2003 Jun; 36(11):1362-8. PubMed ID: 12766829
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women.
Czaja CA; Stapleton AE; Yarova-Yarovaya Y; Stamm WE
Infect Dis Obstet Gynecol; 2007; 2007():35387. PubMed ID: 18288237
[TBL] [Abstract][Full Text] [Related]
10. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.
Uehling DT; Hopkins WJ; Balish E; Xing Y; Heisey DM
J Urol; 1997 Jun; 157(6):2049-52. PubMed ID: 9146577
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide production and resistance to nonoxinol-9 in Lactobacillus spp. isolated from the vagina of reproductive-age women.
Angeles-López M; García-Cano Ramos E; Aquino Santiago C
Rev Latinoam Microbiol; 2001; 43(4):171-6. PubMed ID: 17061505
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis].
Delia A; Morgante G; Rago G; Musacchio MC; Petraglia F; De Leo V
Minerva Ginecol; 2006 Jun; 58(3):227-31. PubMed ID: 16783294
[TBL] [Abstract][Full Text] [Related]
13. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.
Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE
J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718
[TBL] [Abstract][Full Text] [Related]
14. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
Fraga M; Scavone P; Zunino P
Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
[TBL] [Abstract][Full Text] [Related]
15. Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection.
Kwok L; Stapleton AE; Stamm WE; Hillier SL; Wobbe CL; Gupta K
J Urol; 2006 Nov; 176(5):2050-4; discussion 2054. PubMed ID: 17070251
[TBL] [Abstract][Full Text] [Related]
16. The in vitro effect of hydrogen peroxide on vaginal microbial communities.
Strus M; Brzychczy-Włoch M; Gosiewski T; Kochan P; Heczko PB
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):56-63. PubMed ID: 16965352
[TBL] [Abstract][Full Text] [Related]
17. A pilot study evaluating the safety of vaginal administration of a multi-particulate pellet formulation.
Santiago GL; Verstraelen H; Poelvoorde N; De Corte S; Claeys G; Trog M; De Backer E; Saerens B; Vervaet C; De Boeck F; Van Bortel L; Remon JP; Temmerman M; Vaneechoutte M; Verhelst R
Eur J Pharm Biopharm; 2009 Nov; 73(3):399-403. PubMed ID: 19733660
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: the vaginal microflora and bacterial vaginosis.
Verstraelen H
Verh K Acad Geneeskd Belg; 2008; 70(3):147-74. PubMed ID: 18669158
[TBL] [Abstract][Full Text] [Related]
19. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
Zárate G; Nader-Macias ME
Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
[TBL] [Abstract][Full Text] [Related]
20. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME; Betsi GI; Athanasiou S
J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
